KERING (KER-FR) earnings Q2 2025

A Gucci logo is displayed at their store on May 30, 2025 in Washington, DC. Kevin Carter | Getty Images News | Getty Images Gucci-owner Kering on Tuesday posted worse-than-feared second-quarter results and flagged ongoing geopolitical uncertainty as woes persist at the beleaguered luxury group. Sales at the high-end fashion house dropped 15% year-on-year on…

Read More

Paypal (PYPL) Q2 2025 earnings

PayPal reported better-than-expected results for the second quarter but saw slowing growth in transaction margin dollars, a key measure of profitability. The stock slipped more than 8% following the report. Here’s how the company did compared with Wall Street estimates, based on a survey of analysts by LSEG: Earnings per share: $1.40 adjusted vs. $1.30 expected…

Read More

Nearing deal to replace Goldman Sachs as issuer

JPMorgan Chase, already the largest credit card issuer in the U.S., is nearing a deal to take over the Apple Card portfolio from Goldman Sachs, people familiar with the matter told CNBC. The banks declined to comment to CNBC. Apple didn’t immediately return request for comment. Negotiations between JPMorgan and Apple have progressed as earlier…

Read More

Boeing (BA) 2Q 2025 earnings

The nose cone of a Boeing 787 being displayed on the tarmac during the Paris Air Show at Le Bourget Airport, outside Paris, June 25, 2023. Nicolas Economou | Nurphoto | Getty Images Boeing slashed its quarterly losses as sales jumped after it delivered the most airplanes since 2018, the clearest sign yet of improvement at…

Read More

Merck (MRK) earnings report Q2 2025

Merck & Co. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Tuesday, April 8, 2025. Michael Nagle | Bloomberg | Getty Images Merck on Tuesday said it will slash $3 billion in costs by the end of 2027 to be fully reinvested to support new product launches…

Read More

Firms urge for clarity under EU-U.S. trade deal

Shelf of pharmaceutical products. D3sign | Moment | Getty Images Pharma firms are calling for clarity on tariffs imposed under the new U.S.-EU trade agreement, as analysts warn that punitive sector-specific levies could risk blowing up the entire deal. Ambiguity abounds around the terms for pharmaceutical goods under the trade truce agreed Sunday, which imposes…

Read More

Samsung backs AI chip startup Rebellions ahead of IPO

The Rebel-Quad is the second-generation product from Rebellions and is made up of four Rebel AI chips. Rebellions, a South Korean firm, is looking to rival companies like Nvidia in AI chips. Rebellions South Korean artificial intelligence chip startup Rebellions has raised money from tech giant Samsung and is targeting a funding round of up…

Read More